← Back to contracts

Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)

US · MD National Institutes of Health (NIH) grant open #PAR-25-157
Response due Jun 18, 2026 · 00:00 UTC

Summary

The National Institutes of Health (NIH) is soliciting R21 exploratory/developmental research grant applications under the ASCETTS program. The program supports the development and application of cutting-edge technologies to advance translational science. Clinical trials are explicitly excluded from this funding opportunity. Applications are accepted on a rolling basis from December 2024 through June 2026.

What they want

Technical requirements
  • Clinical trials not allowed
  • R21 exploratory/developmental grant mechanism
  • Technology must support translational science applications

Risks & flags

  • No dollar value or budget cap stated — award size is unclear
  • Rolling submission window spanning 18+ months may obscure prioritization of specific applicants

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541714
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Awards Supporting Cutting-Edge Technologie…
Due Jun 18
Onboard ↗